Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Very happy with Q1s! Only caveat are AI revenues
View:
Post by Resilience19 on May 31, 2021 8:41am

Very happy with Q1s! Only caveat are AI revenues

More than happy with revenues, EBITDA+ and cash position.

At this time my only concern are AI revenues that have decreased Q12021 vs Q12020:

All figures are in Canadian dollars unless otherwise noted:

  Q1 2021 Q1 2020 % Change
Total revenues $19,045,888 $809,402 2,253%
COVID-19 Test kits revenue $18,561,296 $0 100%
AI and Technology and Other revenue $484,592 $809,402 -40%
Income/Loss before income taxes $10,482,954 (737,968) 1,521%
Net Income/Loss $9,560,351 (721,761) 1,425%
Income per share - basic $0.03 (0.003) 1,100%
EBITDA $10,684,254 ($737,698) 1,548%

Given Marshalls confidence that Q2 2021 will generate strong AI revenues, I'm hopeful these will be stronger than Q2 2020. This said, weve been seeing COVID-19 testing decreasing M-o-M (according to SCRN NRs), so I think we can expect reduced revenues 2021 Q2 vs Q1, although these should still be very significant (perhaps $15M$) and continue to strengthen cash on hand and EBITDA+ position.  We simply need to score a strong AI contract (i.e. a decent portion of the MDA-DM JV) and we'll be able to continue the year with confidence.

My two cents!
Comment by UprootedData975 on May 31, 2021 9:17am
Agreed with the AI question/concern Though I don't think we can evaluate DM based strictly on SCRN -- Marshall mentioned testing was only increasing in Q2 SCRN posted numbers this morning: The Company recorded Q1 2021 revenue of $6,880,325. Well below DM's revenue, so DM's kit sales' reach is far beyond SCRN.  Long and strong DM!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities